Hélène Massé

890 total citations
30 papers, 196 citations indexed

About

Hélène Massé is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Physiology. According to data from OpenAlex, Hélène Massé has authored 30 papers receiving a total of 196 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Ophthalmology, 14 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Physiology. Recurrent topics in Hélène Massé's work include Retinal Diseases and Treatments (15 papers), Retinal and Optic Conditions (9 papers) and Retinal and Macular Surgery (8 papers). Hélène Massé is often cited by papers focused on Retinal Diseases and Treatments (15 papers), Retinal and Optic Conditions (9 papers) and Retinal and Macular Surgery (8 papers). Hélène Massé collaborates with scholars based in France, Denmark and United Kingdom. Hélène Massé's co-authors include Michel Weber, M Stupfel, Gordon Rustin, Hussam El Chehab, C. Burillon, SP Stenning, Graham M. Mead, R.T.D. Oliver, Émilie Agard and Corinne Dot and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Investigative Ophthalmology & Visual Science.

In The Last Decade

Hélène Massé

28 papers receiving 189 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hélène Massé France 7 119 83 28 27 22 30 196
Martin Grüterich Germany 8 177 1.5× 204 2.5× 31 1.1× 38 1.4× 17 0.8× 11 328
Hande Taylan Şekeroğlu Türkiye 11 93 0.8× 73 0.9× 33 1.2× 24 0.9× 23 1.0× 49 246
Nick George United Kingdom 6 151 1.3× 139 1.7× 35 1.3× 162 6.0× 10 0.5× 8 325
Silvia Muñoz Quiñones Spain 10 215 1.8× 164 2.0× 14 0.5× 18 0.7× 10 0.5× 40 290
J.–P. Nordmann France 10 197 1.7× 98 1.2× 24 0.9× 23 0.9× 11 0.5× 55 284
Alexandros Chatzirallis Greece 8 223 1.9× 162 2.0× 25 0.9× 44 1.6× 10 0.5× 18 271
Özge Yanık Türkiye 11 340 2.9× 215 2.6× 21 0.8× 51 1.9× 8 0.4× 48 394
Solange Milazzo France 9 237 2.0× 149 1.8× 12 0.4× 25 0.9× 7 0.3× 17 297
Mimiwati Zahari Malaysia 12 301 2.5× 155 1.9× 21 0.8× 44 1.6× 21 1.0× 33 380
Denis Plotnikov United Kingdom 9 186 1.6× 234 2.8× 8 0.3× 37 1.4× 7 0.3× 20 432

Countries citing papers authored by Hélène Massé

Since Specialization
Citations

This map shows the geographic impact of Hélène Massé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Massé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Massé more than expected).

Fields of papers citing papers by Hélène Massé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Massé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Massé. The network helps show where Hélène Massé may publish in the future.

Co-authorship network of co-authors of Hélène Massé

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène Massé. A scholar is included among the top collaborators of Hélène Massé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène Massé. Hélène Massé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zanlonghi, Xavier, et al.. (2024). Variable expressivity of the autosomal dominant vitreoretinochoroidopathy (ADVIRC) phenotype associated with a novel variant in BEST1. Ophthalmic Genetics. 45(5). 470–475. 1 indexed citations
2.
Motloch, Karolina, Vincent Soler, Marie‐Noëlle Delyfer, et al.. (2024). Efficacy and Safety of 0.19-mg Fluocinolone Acetonide Implant in Postoperative Cystoid Macular Edema after Pars Plana Vitrectomy. Ophthalmology Retina. 8(12). 1181–1191. 3 indexed citations
3.
Kodjikian, Laurent, Marie‐Bénédicte Rougier, Michel Weber, et al.. (2024). Efficacity and Safety of the Fluocinolone Acetonide Implant in Uveitic Macular Edema: A Real-Life Study from the French Uveitis Network. Journal of Personalized Medicine. 14(3). 245–245. 3 indexed citations
5.
Massé, Hélène, et al.. (2023). Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Diabetic Macular Oedema: the ILUVI1MOIS Study. Ophthalmology and Therapy. 12(5). 2781–2792. 3 indexed citations
6.
Massé, Hélène, et al.. (2021). Corrélations anatomo-fonctionnelles dans la choriorétinopathie de Birdshot : étude prospective monocentrique observationnelle. Journal Français d Ophtalmologie. 44(5). 632–642. 2 indexed citations
7.
Couturier, Aude, Laurent Kodjikian, Stéphanie Baillif, et al.. (2021). Consensus d’experts français sur les critères de choix d’un traitement de 1re intention dans la DMLA néovasculaire et importance du ratio bénéfice/risque à long terme. Journal Français d Ophtalmologie. 44(7). 937–946. 1 indexed citations
8.
Massé, Hélène, et al.. (2021). Étude des récidives exsudatives chez 42 yeux naïfs atteints de dégénérescence maculaire liée à l’âge suivis plus de 2 ans. Journal Français d Ophtalmologie. 44(5). 626–631. 1 indexed citations
9.
Azar, Georges, Benjamin Wolff, F. De Bats, et al.. (2018). Morphological Predictive Features on Spectral-Domain Optical Coherence Tomography for Visual Outcomes in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab. BioMed Research International. 2018. 1–9. 5 indexed citations
10.
Cornut, Pierre‐Loïc, F. De Bats, Vincent Gualino, et al.. (2017). Prise en charge de la DMLA exsudative en France en 2015. Journal Français d Ophtalmologie. 40(9). 723–730. 3 indexed citations
12.
Massé, Hélène, et al.. (2016). DETRIMENTAL EFFECTS OF ACTIVE INTERNAL LIMITING MEMBRANE PEELING DURING EPIRETINAL MEMBRANE SURGERY. Retina. 37(3). 544–552. 34 indexed citations
13.
Massé, Hélène, et al.. (2015). Detrimental effect of active internal limiting membrane peeling during macular pucker surgery: microperimetry analysis. Investigative Ophthalmology & Visual Science. 56(7). 5056–5056. 2 indexed citations
14.
Girmens, Jean‐François, A. Glacet–Bernard, Laurent Kodjikian, et al.. (2015). Prise en charge de l’œdème maculaire secondaire à une occlusion veineuse rétinienne. Journal Français d Ophtalmologie. 38(3). 253–263. 2 indexed citations
15.
Massé, Hélène, Benjamin Wolff, Pierre‐Loïc Cornut, et al.. (2015). Vue d’ensemble des pratiques médicales dans la DMLA exsudative en France. Journal Français d Ophtalmologie. 39(1). 40–47. 6 indexed citations
16.
Malclès, Ariane, Émilie Agard, Hussam El Chehab, et al.. (2013). Migration en chambre antérieure de l’implant intravitréen de dexaméthasone Ozurdex® chez le pseudophake : à propos de trois cas. Journal Français d Ophtalmologie. 36(4). 362–367. 25 indexed citations
17.
Massé, Hélène, et al.. (2009). Mitoxantrone Therapy for Acute Posterior Multifocal Placoid Pigment Epitheliopathy with Cerebral Vasculitis. Case Reports in Medicine. 2009. 1–3. 6 indexed citations
18.
19.
Massé, Hélène, et al.. (2002). L'analyse différenciée selon les sexes au gouvernement du Québec : vers une mobilisation interne et des alliances stratégiques pour l'égalité. SHILAP Revista de lepidopterología. 43–54. 6 indexed citations
20.
Stupfel, M, et al.. (1980). Grouping and respiratory behavior induced in rats and quails by LD12:12 illumination. Physiology & Behavior. 25(3). 439–447. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026